|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 637.20 INR | +1.57% |
|
+3.50% | +5.43% |
| 01-09 | Vedanta says NCLT Mumbai approves company petition filed by TSPL | RE |
| 01-08 | Vedanta clarifies report "Delhi HC agrees to examine government's refusal to extend Vedanta's contract" | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.73 | 11.78 | 7.79 | 8.09 | 9.99 | |||||
Return on Total Capital | 8.76 | 15.58 | 11.09 | 12.04 | 14.31 | |||||
Return On Equity % | 20.16 | 29.62 | 21.95 | 16.48 | 42.86 | |||||
Return on Common Equity | 19.85 | 29.46 | 20.18 | 12.09 | 41.67 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 54.07 | 54.63 | 45.9 | 49.35 | 49.73 | |||||
SG&A Margin | 3.36 | 2.18 | 2.18 | 2.38 | 2.37 | |||||
EBITDA Margin % | 31.44 | 34.29 | 24.1 | 25.06 | 27.96 | |||||
EBITA Margin % | 22.99 | 27.65 | 17.07 | 17.81 | 20.98 | |||||
EBIT Margin % | 22.81 | 27.51 | 16.85 | 17.59 | 20.81 | |||||
Income From Continuing Operations Margin % | 17.25 | 18.01 | 9.94 | 5.3 | 13.57 | |||||
Net Income Margin % | 13.31 | 14.28 | 7.25 | 2.98 | 9.9 | |||||
Net Avail. For Common Margin % | 13.31 | 14.28 | 7.25 | 2.98 | 9.9 | |||||
Normalized Net Income Margin | 8.17 | 12.12 | 6.06 | 5.31 | 6.48 | |||||
Levered Free Cash Flow Margin | 7.7 | 8.98 | 12.15 | -0.56 | 5.38 | |||||
Unlevered Free Cash Flow Margin | 11.2 | 11.07 | 14.6 | 3.08 | 8.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.47 | 0.69 | 0.74 | 0.74 | 0.77 | |||||
Fixed Assets Turnover | 0.84 | 1.26 | 1.34 | 1.25 | 1.23 | |||||
Receivables Turnover (Average Receivables) | 28.07 | 31.1 | 32.46 | 37.21 | 41.62 | |||||
Inventory Turnover (Average Inventory) | 3.34 | 4.18 | 4.4 | 4.29 | 4.91 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.95 | 1.04 | 0.69 | 0.66 | 0.7 | |||||
Quick Ratio | 0.6 | 0.56 | 0.27 | 0.21 | 0.31 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.53 | 0.38 | 0.45 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 13 | 11.74 | 11.25 | 9.84 | 8.77 | |||||
Days Outstanding Inventory (Average Inventory) | 109.3 | 87.4 | 83.03 | 85.38 | 74.27 | |||||
Average Days Payable Outstanding | 75.56 | 50.61 | 48.49 | 56.89 | 47.9 | |||||
Cash Conversion Cycle (Average Days) | 46.74 | 48.52 | 45.78 | 38.33 | 35.14 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 84.82 | 78.08 | 162.52 | 208.48 | 170.35 | |||||
Total Debt / Total Capital | 45.89 | 43.85 | 61.91 | 67.58 | 63.01 | |||||
LT Debt/Equity | 49.25 | 43.96 | 88.25 | 121.63 | 99.13 | |||||
Long-Term Debt / Total Capital | 26.65 | 24.68 | 33.62 | 39.43 | 36.67 | |||||
Total Liabilities / Total Assets | 58.31 | 58.36 | 74.83 | 77.95 | 73.56 | |||||
EBIT / Interest Expense | 4.07 | 8.23 | 4.29 | 3.02 | 3.62 | |||||
EBITDA / Interest Expense | 5.65 | 10.27 | 6.16 | 4.33 | 4.91 | |||||
(EBITDA - Capex) / Interest Expense | 4.24 | 7.85 | 3.75 | 2.31 | 2.96 | |||||
Total Debt / EBITDA | 2.38 | 1.43 | 2.28 | 2.45 | 2.14 | |||||
Net Debt / EBITDA | 1.24 | 0.73 | 1.76 | 2.1 | 1.7 | |||||
Total Debt / (EBITDA - Capex) | 3.17 | 1.87 | 3.74 | 4.59 | 3.56 | |||||
Net Debt / (EBITDA - Capex) | 1.65 | 0.96 | 2.89 | 3.93 | 2.83 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.83 | 51.07 | 10.79 | -2.55 | 6.45 | |||||
Gross Profit, 1 Yr. Growth % | 12.26 | 52.63 | -6.91 | 4.77 | 7.26 | |||||
EBITDA, 1 Yr. Growth % | 27.16 | 64.73 | -22.1 | 1.31 | 18.76 | |||||
EBITA, 1 Yr. Growth % | 58.75 | 81.7 | -31.62 | 1.72 | 25.39 | |||||
EBIT, 1 Yr. Growth % | 59.43 | 82.22 | -32.14 | 1.69 | 25.96 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -416.86 | 57.73 | -38.83 | -48.02 | 172.38 | |||||
Net Income, 1 Yr. Growth % | -274.1 | 62.06 | -43.76 | -59.91 | 253.57 | |||||
Normalized Net Income, 1 Yr. Growth % | 105.21 | 124.2 | -44.65 | -14.49 | 29.7 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -272.94 | 61.84 | -43.79 | -59.99 | 241.13 | |||||
Accounts Receivable, 1 Yr. Growth % | 29.44 | 41.68 | -18.84 | -10.14 | 0.8 | |||||
Inventory, 1 Yr. Growth % | -12.42 | 50.2 | 9.94 | -21.32 | 8.2 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.48 | 2.82 | 4.54 | 5.61 | 9.95 | |||||
Total Assets, 1 Yr. Growth % | 1.13 | 6.94 | -1.02 | -2.34 | 6.54 | |||||
Tangible Book Value, 1 Yr. Growth % | 13.07 | 5.88 | -43.48 | -25.72 | 39.05 | |||||
Common Equity, 1 Yr. Growth % | 13.99 | 4.99 | -39.7 | -22.07 | 34.14 | |||||
Cash From Operations, 1 Yr. Growth % | 24.25 | 45.8 | -5.43 | 7.83 | 10.96 | |||||
Capital Expenditures, 1 Yr. Growth % | -11.88 | 54.37 | 29.7 | 21.51 | 1.51 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -260.97 | 79.38 | 51.6 | -104.77 | -1.12K | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -854.46 | 51.17 | 47.5 | -78.48 | 210.64 | |||||
Dividend Per Share, 1 Yr. Growth % | 143.59 | 373.68 | 125.56 | -70.94 | 47.46 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.32 | 25.24 | 29.37 | 3.91 | 1.85 | |||||
Gross Profit, 2 Yr. CAGR % | 2.87 | 30.9 | 19.2 | -1.24 | 6.01 | |||||
EBITDA, 2 Yr. CAGR % | 6.56 | 44.73 | 13.27 | -11.16 | 9.69 | |||||
EBITA, 2 Yr. CAGR % | 11.9 | 69.84 | 11.46 | -16.6 | 12.94 | |||||
EBIT, 2 Yr. CAGR % | 11.98 | 70.45 | 11.2 | -16.93 | 13.18 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 24.5 | 123.56 | -1.78 | -43.61 | 18.99 | |||||
Net Income, 2 Yr. CAGR % | 28.15 | 67.97 | -4.53 | -52.52 | 19.06 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.61 | 114.49 | 11.4 | -31.2 | 5.31 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 28.07 | 67.3 | -4.62 | -52.58 | 16.82 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.37 | 35.42 | 7.23 | -14.6 | -4.82 | |||||
Inventory, 2 Yr. CAGR % | -7.9 | 15.92 | 28.23 | -6.99 | -7.49 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -6.33 | 0.65 | 3.67 | 5.07 | 7.76 | |||||
Total Assets, 2 Yr. CAGR % | -4.13 | 4 | 2.83 | -1.93 | 2.01 | |||||
Tangible Book Value, 2 Yr. CAGR % | 0.09 | 9.41 | -22.64 | -35.2 | 1.63 | |||||
Common Equity, 2 Yr. CAGR % | -0.02 | 9.39 | -20.44 | -31.45 | 2.24 | |||||
Cash From Operations, 2 Yr. CAGR % | 0.47 | 34.59 | 17.42 | 0.98 | 9.38 | |||||
Capital Expenditures, 2 Yr. CAGR % | -12.25 | 16.64 | 41.5 | 25.54 | 11.06 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -25.66 | 68.44 | 63.95 | -73.85 | -30.25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -20.38 | 235.69 | 48.62 | -44.97 | -18.24 | |||||
Dividend Per Share, 2 Yr. CAGR % | -29.01 | 239.68 | 226.87 | -19.03 | -34.53 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.56 | 12.96 | 20.22 | 17.71 | 4.75 | |||||
Gross Profit, 3 Yr. CAGR % | 3.15 | 17.33 | 16.84 | 14.18 | 1.52 | |||||
EBITDA, 3 Yr. CAGR % | 2.69 | 23.22 | 17.72 | 9.14 | -2.14 | |||||
EBITA, 3 Yr. CAGR % | 1.66 | 31.53 | 25.41 | 8.11 | -4.46 | |||||
EBIT, 3 Yr. CAGR % | 1.63 | 31.71 | 25.39 | 7.94 | -4.56 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.16 | 34.72 | 45.13 | -20.55 | -4.68 | |||||
Net Income, 3 Yr. CAGR % | 3.91 | 38.58 | 16.64 | -28.51 | -7.28 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.69 | 53.18 | 36.56 | 2 | -15.01 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.3 | 38.46 | 16.31 | -28.6 | -8.46 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.19 | 7.49 | 14.17 | 1.1 | -9.75 | |||||
Inventory, 3 Yr. CAGR % | -2.2 | 9.18 | 13.73 | 8.96 | -2.01 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.67 | -3.38 | 1.93 | 4.32 | 6.67 | |||||
Total Assets, 3 Yr. CAGR % | 0.2 | -0.57 | 2.26 | 0.91 | 0.82 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.18 | 1.99 | -12.21 | -23.68 | -16.42 | |||||
Common Equity, 3 Yr. CAGR % | -0.55 | 1.62 | -10.31 | -20.99 | -14.26 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.36 | 13.75 | 19.66 | 14.14 | 4.21 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.08 | 5.93 | 20.84 | 34.49 | 16.95 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 82.72 | -0.87 | 62 | -50.51 | -11.34 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 71.88 | -1.81 | 154.4 | -23.18 | -2.02 | |||||
Dividend Per Share, 3 Yr. CAGR % | -23.48 | 33.65 | 196.35 | 45.89 | -1.12 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.29 | 12.76 | 9.81 | 9.25 | 12.51 | |||||
Gross Profit, 5 Yr. CAGR % | 8.69 | 13.6 | 9.29 | 9.51 | 12.38 | |||||
EBITDA, 5 Yr. CAGR % | 12.38 | 15.91 | 6.8 | 8.1 | 14.44 | |||||
EBITA, 5 Yr. CAGR % | 24.6 | 18.89 | 5.47 | 9.61 | 20.26 | |||||
EBIT, 5 Yr. CAGR % | 24.67 | 18.97 | 5.36 | 9.53 | 20.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.39 | 15.94 | 1.16 | -4.91 | 34.05 | |||||
Net Income, 5 Yr. CAGR % | -1.11 | 22 | 0.44 | -9.71 | 17.6 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.02 | 47.58 | 7.94 | 11.21 | 23.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.54 | 16.52 | 0.06 | -9.8 | 16.51 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.77 | 15.29 | 0.23 | -1.96 | 6.16 | |||||
Inventory, 5 Yr. CAGR % | 6.92 | 12.27 | 9.46 | 2.31 | 4.71 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.86 | 2.58 | 3.07 | -0.08 | 4.22 | |||||
Total Assets, 5 Yr. CAGR % | -1 | -0.04 | 1.24 | -1.14 | 2.06 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.54 | 4.61 | -5.4 | -14.94 | -6.91 | |||||
Common Equity, 5 Yr. CAGR % | 7.18 | 1.56 | -9.04 | -13.18 | -5.48 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.31 | 14.1 | 13.75 | 8.46 | 15.44 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.54 | 14.02 | 13.46 | 13.38 | 16.83 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -23.58 | 0.59 | 74.35 | -41.97 | 14.34 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -19.52 | -0.02 | 61.78 | -22.26 | 60.04 | |||||
Dividend Per Share, 5 Yr. CAGR % | 22.1 | 91.44 | 36.78 | 9.37 | 61.99 |
- Stock Market
- Equities
- VEDL Stock
- Financials Vedanta Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















